Kellax Surgicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 8.25 Cr
About Kellax Surgicals
Kellax Surgicals Private Limited (KSPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 March 2018 (Six years and ten months 14 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.25 Cr.
Dominic Savio, Sinu Dominic, Prasanth Nair, and One other member serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TZ2018PTC030215
-
Company No.
030215
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Mar 2018
-
Date of AGM
29 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Kellax Surgicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sinu Dominic
|
Managing Director | 18-Sep-2018 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Roopa Dileep
|
Director | 29-Oct-2020 | Current |
|
Dominic Savio
|
Director | 07-May-2018 | Current |
|
Prasanth Nair
|
Director | 29-Mar-2019 | Current |
Financial Performance of Kellax Surgicals.
Enhance accessibility to Kellax Surgicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kellax Surgicals?
In 2019, Kellax Surgicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Amanemu Retail Private LimitedRoopa Dileep is a mutual person
Charges (Loans)
₹82.50 M
₹0
Charges Breakdown by Lending Institutions
- The South Indian Bank Limited : 8.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Sep 2020 | The South Indian Bank Limited | ₹1.05 Cr | Open |
| 31 Dec 2019 | The South Indian Bank Limited | ₹7.20 Cr | Open |
How Many Employees Work at Kellax Surgicals?
Unlock and access historical data on people associated with Kellax Surgicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kellax Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kellax Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
